Virtus Biotech Clinical Trials ETF

Virtus Biotech Clinical Trials ETF is an ETF issued by Virtus Investment Partners, Inc. on Dec 16 2014. The main focus of this ETF, which is in the "Equity" asset class, is determined as "Health care". As of today, the price of BBC ETF according to its net asset value is premiumed at 0.02%. While the total value of the fund shows $6.71M increase compared to the previous month, its price is traded daily at a decrease of -0.13%. The annual dividend yield of BBC ETF is 1.57%, whereas its main asset area is North America. BBC ETF, whose 24-hour total volume is $4.26K, has experienced a $6.97M cash inflow in the last month. In addition, Virtus Biotech Clinical Trials ETF's one-year net asset value total return is 123.66%.